Clinical Trials for CorrectSequence Therapeutics

Explore 8 clinical trials worldwide

Showing 1-8 of 8 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CorrectSequence Therapeutics

Clinical Trials (8)

NCT07176923
CS-121 APOC3 Base Editing in FCS
EARLY_PHASE1Not yet recruiting
15 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06717932
A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
N/AEnrolling by invitation
8 participants
Started: May 31, 2025 · Completed: Nov 30, 2039
1 condition1 sponsor1 location
NCT06685536
A Long-term Follow-up Study in Participants Who Received CS-101
N/AEnrolling by invitation
5 participants
Started: Jan 18, 2025 · Completed: Jul 31, 2039
1 condition2 sponsors1 location
NCT06565026
CS-206 in Patients With Sickle Cell Disease
EARLY_PHASE1Recruiting
5 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06291961
A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major
PHASE1Recruiting
8 participants
Started: Apr 18, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT06328764
CS-101 in Patients With β-thalassemia
EARLY_PHASE1Enrolling by invitation
10 participants
Started: Mar 19, 2024 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT06065189
Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major
EARLY_PHASE1Active, not recruiting
5 participants
Started: Nov 7, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT06024876
A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia
EARLY_PHASE1Active, not recruiting
5 participants
Started: Aug 26, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location